| [1] |
Jarow JP. Use of External Controls in Regulatory Decision-Making[J]. Clin Pharmacol Ther, 2017, 101(5)：595-596.
|
| [2] |
Knottnerus JA,Tugwell P. Real world research[J]. J Clin Epidemiol, 2010, 63(10)：1051-1052.
|
| [3] |
Gupta S,Wang H,Skolnik N, et al. Treatment dosing patterns and clinical outcomes for patients with type 2 diabetes starting or switching to treatment with insulin glargine (300 units per milliliter) in a real-world setting: a retrospective observational study[J]. Adv Ther, 2018, doi: 10.1007/s12325-017-0651-3.[Epub ahead of print].
URL
|
| [4] |
Zhao YJ,Teng M,Khoo AL, et al. A propensity score matched comparison of biodegradable polymer versus second-generation durable polymer drug-eluting stents in a real-world population[J]. Cardiovasc Ther, 2018, doi: 10.1111/1755-5922.12319.[Epub ahead of print].
URL
|
| [5] |
Shu H,Lu J,Zhang P, et al. Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: an analysis of the ORBIT study[J]. Diabetes Metab Res Rev, 2018, doi: 10.1002/dmrr.2977.[Epub ahead of print].
URL
|
| [6] |
De Potter T,Van Herendael H,Balasubramaniam R, et al. Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry[J]. Europace, 2018, doi: 10.1093/europace/eux290.[Epub ahead of print].
URL
|
| [7] |
Bartlett SJ,Barnes T,McIvor RA. Integrating patients into meaningful real-world research[J]. Ann Am Thorac Soc, 2014, 11 Suppl 2: S112-117.
|
| [8] |
孙鑫,谭婧,唐立, 等. 重新认识真实世界研究[J]. 中国循证医学杂志, 2017, 17(02)：126-130.
|
| [9] |
Krishnan JA,Schatz M,Apter AJ. A call for action: Comparative effectiveness research in asthma[J]. J Allergy Clin Immunol, 2011, 127(1)：123-127.
|
| [10] |
Travers J,Marsh S,Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply？[J]. Thorax, 2007, 62(3)：219-223.
|
| [11] |
Kardos P,Worsley S,Singh D, et al. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11：2885-2895.
|
| [12] |
Silverman SL. From randomized controlled trials to observational studies[J]. Am J Med, 2009, 122(2)：114-120.
|
| [13] |
Roche N,Reddel H,Martin R, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness[J]. Ann Am Thorac Soc, 2014, 11 Suppl 2：S99-104.
|
| [14] |
Altman RD,Schemitsch E,Bedi A. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid[J]. Semin Arthritis Rheum, 2015, 45(2)：132-139.
|
| [15] |
Orchard JW. Systematic review is the highest level of evidence for knee osteoarthritis injection options, not expert society guidelines[J]. Br J Sports Med, 2017, 51(7)：622.
|
| [16] |
Gold R,Bunce A,Cowburn S, et al. Cardiovascular care guideline implementation in community health centers in Oregon: a mixed-methods analysis of real-world barriers and challenges[J]. BMC Health Serv Res, 2017, 17(1)：253.
|
| [17] |
Jevsevar D,Donnelly P,Brown GA, et al. Viscosupplementation for Osteoarthritis of the Knee: A Systematic Review of the Evidence[J]. J Bone Joint Surg Am, 2015, 97(24)：2047-2060.
|
| [18] |
Strand V,McIntyre LF,Beach WR, et al. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials[J]. J Pain Res, 2015, 8：217-228.
|
| [19] |
Richette P,Chevalier X,Ea HK, et al. Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias[J]. RMD Open, 2015, 1(1)：e000071.
|
| [20] |
Bannuru RR,Natov NS,Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis[J]. Arthritis Rheum, 2009, 61(12)：1704-1711.
|
| [21] |
Dasa V,DeKoven M,Sun K, et al. Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database[J]. Drugs Context, 2016, 5：212296.
|
| [22] |
Petrella RJ,Wakeford C. Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada[J]. Drug Des Devel Ther, 2015, 9：5633-5640.
|
| [23] |
Price D,Chisholm A,van der Molen T, et al. Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness[J]. Curr Allergy Asthma Rep, 2011, 11(6)：526-538.
|
| [24] |
Doghramji PP,Fermer S,Wood R, et al. Management of gout in the real world: current practice versus guideline recommendations[J]. Postgrad Med, 2016, 128(1)：106-114.
|
| [25] |
Lian J,Liang Y. Diabetes management in the real world and the impact of adherence to guideline recommendations[J]. Curr Med Res Opin, 2014, 30(11)：2233-2240.
|
| [26] |
Montie JE. Guideline application and the real world[J]. Urol Oncol, 2014, 32(4)：377-379.
|